The industry that treats cytomegalovirus treatment market share is leading the charge in combating a powerful viral enemy that often remains unchecked. Those with HIV and recipients of transplants are two populations of people whose immune systems are weakened by the potentially fatal herpesvirus CMV. As a result, creating efficient treatments has become a major …